Addex Therapeutics Ltd. (ADXN)
3.18
+0.08
(+2.58%)
USD |
NASDAQ |
Oct 06, 16:00
2.97
-0.21
(-6.60%)
After-Hours: 20:00
Addex Therapeutics Max Drawdown (5Y) : 98.94% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 98.94% |
| August 31, 2026 | 98.94% |
| July 31, 2026 | 98.94% |
| June 30, 2026 | 98.94% |
| May 31, 2026 | 98.94% |
| April 30, 2026 | 98.94% |
| March 31, 2026 | 98.94% |
| February 28, 2026 | 98.94% |
| January 31, 2026 | 98.94% |
| December 31, 2025 | 98.94% |
| November 30, 2025 | 98.94% |
| October 31, 2025 | 98.94% |
| September 30, 2025 | 98.94% |
| August 31, 2025 | 98.94% |
| July 31, 2025 | 98.94% |
| June 30, 2025 | 98.94% |
| May 31, 2025 | 98.94% |
| April 30, 2025 | 98.94% |
| March 31, 2025 | 98.94% |
| February 28, 2025 | 98.94% |
| January 31, 2025 | 98.94% |
| December 31, 2024 | 98.94% |
| November 30, 2024 | 98.94% |
| October 31, 2024 | 98.94% |
| September 30, 2024 | 98.94% |
| Date | Value |
|---|---|
| August 31, 2024 | 98.94% |
| July 31, 2024 | 98.94% |
| June 30, 2024 | 98.94% |
| May 31, 2024 | 98.94% |
| April 30, 2024 | 98.94% |
| March 31, 2024 | 98.94% |
| February 29, 2024 | 98.94% |
| January 31, 2024 | 98.94% |
| December 31, 2023 | 98.94% |
| November 30, 2023 | 98.91% |
| October 31, 2023 | 98.73% |
| September 30, 2023 | 98.57% |
| August 31, 2023 | 98.09% |
| July 31, 2023 | 97.85% |
| June 30, 2023 | 97.85% |
| May 31, 2023 | 97.71% |
| April 30, 2023 | 97.71% |
| March 31, 2023 | 97.71% |
| February 28, 2023 | 97.71% |
| January 31, 2023 | 97.71% |
| December 31, 2022 | 97.71% |
| November 30, 2022 | 97.10% |
| October 31, 2022 | 96.98% |
| September 30, 2022 | 96.77% |
| August 31, 2022 | 96.21% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Novartis AG | 20.42% |
| Roche Holding AG | 40.92% |
| Oculis Holding AG | -- |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -75.63 |
| Beta (5Y) | 1.519 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 96.34% |
| Historical Sharpe Ratio (5Y) | -0.6273 |
| Historical Sortino (5Y) | -1.198 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 41.05% |